XORTX Therapeutics Inc. (NASDAQ: XRTX), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announced that its Pharmacokinetics Bridging Study – XRX-OXY-101 – Part 2 showed a significant increase in oral bioavailability of XORTX’s proprietary oxypurinol formulation provided with...
Harmony Biosciences, Inc. (NASDAQ: HRMY) is a commercial-stage biopharmaceutical Company developing novel therapeutics for rare and orphan diseases, focusing on central nervous system disorders. Pitolisant, its lead product candidate, is a first-in-class histamine 3 (H3) receptor antagonist/inverse agonist that can help treat excessive daytime sleepiness...
Covid-19 has bought many biotech companies into the limelight, all promising a possible solution to the pandemic that has disrupted lives worldwide. In February 2021, Ocugen, Inc. (NASDAQ: OCGN) shares catapulted after news of the Company signing a binding letter of intent (LOI) with Bharat...
TherapeuticsMD (NASDAQ: TXMD), is a women’s healthcare Company focused on creating novel solutions for challenges encountered by women in areas such as family planning, reproductive health, and menopause management. The Company’s product offerings include Annovera, a progestin/estrogen CHC vaginal birth control ring intended for contraception,...
Genius Brands International, Inc. (NASDAQ: GNUS), formerly known as Pacific Entertainment Corporation, develops animated “content with a purpose” for toddlers to tweens worldwide. The Company’s programs include Superhero Kindergarten, developed in association with Stan Lee; Llama Llama streaming on Netflix; Rainbow Rangers on Nick Jr;...
TOMI Environmental Solutions (OTCQB: TOMZ), a Company that offers indoor and outdoor disinfection and decontamination services globally, announced a partnership with Rock Emergency, for the use of its SteraMist line of products, to combat the rapid spread of COVID-19 in the U.S. Rock Environment will...
OptimizeRx Corporation (NASDAQ: OPRX), a pioneer in the cloud-based digital health messaging solutions arena that create a bridge between pharmaceutical Companies and healthcare providers, announced the signing of its largest ever enterprise deal for 12 months of access to its platform and core set of...
Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical Company engaged in developing candidates for oncology, auto-immune and chronic pain, has announced the withdrawal of its application for oxycodegol (formerly NKTR-181), as it received adverse advisory committee decision from both Anesthetic and Analgesic Drug Products Advisory Committee, and...
Huntington’s disease is a progressive degeneration of the neurons in the brain resulting in loss of cognition, motor ability, uncontrolled movements and emotional distress. The disease can be categorized into adult onset, which manifests in the form of depression, irritability, lack of coordination and poor...
Wave Life Sciences (NASDAQ: WVE), a clinical-stage Company developing novel stereopure oligonucleotides to treat genetic defects, announced topline data from an ongoing Phase 1b/2a PRECISION-HD2 trial evaluating the safety and efficacy of WVE-120102, a first-in-class allele-selective approach to treat Huntington’s disease (HD). The study shows...
